Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: ease....

RE: ease....

posted on Feb 20, 2006 02:39PM
Arthur,

I would like to comment on post regarding how ``those in power`` might value their stock. For a while a few days ago I was concerned that PTSC might be a target of a buyout based on the belief that a group of major shareholders would have a price where the might decide to ``cash out``, maybe leaving others of us holding the bag. However, it appears that there is a stipulation in the merger agreement between TPL and PTSC stating that if there is a buy out of PTSC the all rights to the IP portfolio goes to TPL exclusively. Hence, there is no incentive for another company besides TPL to attempt an acquisition. This implies that the major shareholders in PTSC are in for the long haul too. This certainly seems to be Pohl`s goal now. I suspect he will be awarded options based on share price appreciation. Partly for that reason I believe we will see future efforts to reduce the outstanding shares and eventually seek NASDAQ listing.

Walt

Share
New Message
Please login to post a reply